Investigational Site Number: 2500003

Toulouse 31400

2 studies enrolling now · 7 studies all time

What they study most

Breast Cancer, Crohn's Disease, Neurodermatitis, Non-small Cell Lung Cancer, Plasma Cell Myeloma Recurrent, Pleural Mesothelioma, Relapsing Multiple Sclerosis, Ulcerative Colitis

Studies at this site

• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease. — Recruiting now
• A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis — Recruiting now
• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling
• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) — Stopped early
• Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer — Stopped early
• Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis — Completed
• Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2) — Completed